Primary links
- Introduction
- Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists
- American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
- Introduction
- Methods
- Diagnosis: Histopathology and Differential Diagnosis
- Initial Evaluations
- Establishing Treatment Goals
- Approaches to Locoregional Disease
- Approaches to Advanced Metastatic Disease (Stage IVC)
- Palliative Care and Hospice
- Surveillance and Long-Term Monitoring
- Summary
- Acknowledgments
- Author Disclosure Statement
- References
- American Thyroid Association Design and Feasibility of a Prospective Randomized Controlled Trial of Prophylactic Central Lymph
- American Thyroid Association Statement on the Essential Elements of Interdisciplinary Communication of Perioperative Information
- Introduction
- Methods
- Results
- Conclusions
- Author Disclosure Statement
- References
- Appendix A. Sample Narrative Operative Report for Total Thyroidectomy
- Appendix B: Essential Data Fields for Synoptic Reporting on Patients with Thyroid Cancer
- Appendix C: Electronic Template for Day-of-Thyroidectomy Letter to Referring Provider(s)
- Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpart
- Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Assoc
- Introduction
- Methods of Development of Evidence-Based Guidelines
- Results
- [B] How should clinically or incidentally discovered thyrotoxicosis be evaluated and initially managed?
- [C] How should overt hyperthyroidism due to GD be managed?
- [D] If 131I therapy is chosen, how should it be accomplished?
- [E] If antithyroid drugs are chosen as initial management of GD, how should the therapy be managed?
- [F] If thyroidectomy is chosen for treatment of GD, how should it be accomplished?
- [G] How should thyroid nodules be managed in patients with GD?
- [H] How should thyroid storm be managed?
- [I] How should overt hyperthyroidism due to TMNG or TA be managed?
- [J] If 131I therapy is chosen, how should it be accomplished?
- [K] If surgery is chosen, how should it be accomplished?
- [L] Is there a role for antithyroid drug therapy in patients with TMNG or TA?
- [M] Is there a role for radiofrequency, thermal, or alcohol ablation in the management of TA or TMNG?
- [N] How should GD be managed in children and adolescents?
- [O] If antithyroid drugs are chosen as initial management of GD in children, how should the therapy be managed?
- [P] If radioactive iodine is chosen as treatment for GD in children, how should it be accomplished?
- [Q] If thyroidectomy is chosen as treatment for GD in children, how should it be accomplished?
- [R] How should SH be managed?
- [S] How should hyperthyroidism in pregnancy be managed?
- [T] How should hyperthyroidism be managed in patients with Graves' ophthalmopathy?
- [U] How should overt drug-induced thyrotoxicosis be managed?
- [V] How should thyrotoxicosis due to destructive thyroiditis be managed?
- [W] How should thyrotoxicosis due to unusual causes be managed?
- Acknowledgments
- Disclosure Statement
- Appendix A
- References
- Radiation Safety in the Treatment of Patients with Thyroid Diseases by Radioiodine 131I: Practice Recommendations of the America
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
- Official Italian Translation of the 2009 American Thyroid Association Management Guidelines for Patients with Thyroid Nodules an
- Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
- Consensus Statement on the Terminology and Classification of Central Neck Dissection for Thyroid Cancer
Author Disclosure Statement
None of the members of the Guidelines task force had any conflicts of interest.